Brian Shuster Chief Business Officer

Brian joined as Chief Business Officer at Orna via the acquisition of ReNAgade Therapeutics in 2024. He is experienced in acquisitions, divestitures, partnerships, financings, licensing, and venture capital across biotech, pharmaceutical, medical device and consumer health sectors. Brian joined ReNAgade Thereapeutics as Chief Business Officer from Corporate Development roles at BMS and Johnson & Johnson, where Brian executed 25 strategic transactions, including the separation of J&J’s Consumer Health business in 2022.

Prior to Johnson & Johnson, Brian was an investment banker at JPMorgan, where he had extensive CEO, CFO, and board-level interactions regarding strategy development/execution while building/maintaining biopharma industry relationships. Brian executed 14 M&A transactions, and was responsible for marketing materials, strategic and financial partner approach, valuation, and negotiations. In addition, Brian executed 30 financings across various capital markets, and led preparation of offering memorandums, due diligence sessions, management presentations, and investor roadshows.

Brian holds a Bachelor of Mechanical Engineering from Villanova University and an MBA from Stern School of Business at New York University. Prior to business school, Brian was an Officer in the US Navy Civil Engineer Corps, where he received two Navy Commendation Medals for his service.